These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 27239883

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better? Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Doran E.
    Int J Health Policy Manag; 2016 Feb 21; 5(5):333-5. PubMed ID: 27239884
    [Abstract] [Full Text] [Related]

  • 3. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
    Kim H.
    Int J Health Policy Manag; 2015 Aug 25; 4(12):813-21. PubMed ID: 26673465
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Direct-to-physician and direct-to-consumer advertising: Time to have stringent regulations.
    Kannan S, Gowri S, Tyagi V, Kohli S, Jain R, Kapil P, Bhardwaj A.
    Int J Risk Saf Med; 2015 Aug 25; 27(2):77-83. PubMed ID: 26410010
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites.
    Tyrawski J, DeAndrea DC.
    J Med Internet Res; 2015 Jun 01; 17(6):e130. PubMed ID: 26032738
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of FDA Actions, DTCA, and Public Information on the Market for Pain Medication.
    Bradford WD, Kleit AN.
    Health Econ; 2015 Jul 01; 24(7):859-75. PubMed ID: 25059655
    [Abstract] [Full Text] [Related]

  • 17. Trends in direct-to-consumer advertising of prescription contraceptives.
    Wu MH, Bartz D, Avorn J, Seeger JD.
    Contraception; 2016 May 01; 93(5):398-405. PubMed ID: 26808088
    [Abstract] [Full Text] [Related]

  • 18. A survey of perceptions and attitudes about direct-to-consumer advertising of prescription drugs among college students in South Korea.
    Yang YM, Lee JJ, Jeong E, Kim SY, Han MA, Choi EJ.
    PLoS One; 2018 May 01; 13(7):e0201108. PubMed ID: 30040833
    [Abstract] [Full Text] [Related]

  • 19. Problems associated with direct-to-consumer advertising (DTCA) of restricted, implantable medical devices: should the current regulatory approach be changed?
    Patsner B.
    Food Drug Law J; 2009 May 01; 64(1):1-41. PubMed ID: 19998571
    [Abstract] [Full Text] [Related]

  • 20. Effects of conflicting prescription drug information from direct-to-consumer advertising and drug injury advertising on patients' beliefs and medication adherence.
    Im H, Huh J.
    Res Social Adm Pharm; 2022 Jul 01; 18(7):3119-3130. PubMed ID: 34454872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.